Skip to main content

Table 2 MR-Imaging data

From: Characteristics of carotid atherosclerotic plaques of chronic lipid apheresis patients as assessed by In Vivo High-Resolution CMR - a comparative analysis

 

Lipid apheresis group

Control group

p-value*

 

(n=32 arteries)

(n=32 arteries)

 

Lumen Area

15.9 ± 6.3

13.0 ± 7.6

ns

[mm2, Minimum]

Wall Area

49.7 ± 11.8

59.6 ± 21.6

0.03

[mm2, Maximum]

Normalized Wall Index

0.61 ± 0.09

0.72 ± 0.12

<0.001

[Maximum]

Outer Wall Area

105.4 ± 28.3

102.0 ± 35.4

ns

[mm2, Maximum]

Plaque Components (quantitative)

Necrotic Lipid Core

5.0 ± 9.4

11.6 ± 13.4

0.025

[% of Vessel Wall, Maximum]

Intraplaque Hemorrhage

2.1 ± 8.8

2.3 ± 6.8

ns

[% of Vessel Wall, Maximum]

Calcifications

4.8 ± 6.0

5.3 ± 6.1

ns

[% of Vessel Wall, Maximum]

Prevalence of Plaque Components

Necrotic Lipid Core [%]

28.1

56.3

0.025

Intraplaque Hemorrhage [%]

9.4

15.6

ns

Calcifications [%]

53.1

56.3

ns

American Heart Association (AHA) Lesion Type

Type I [%]

15.6

12.5

ns

Type III [%]

25.0

15.6

ns

Type IV/V [%]

13.0

37.5

0.023

Type VI [%]

9.4

15.6

ns

Type VII [%]

37.5

18.8

ns

Type VIII [%]

0

0

ns

  1. * Unpaired t-test; SD=Standard Deviation.